Unexplained weight loss (UWL), defined as a decrease of 5% or more in body weight over a period of 6-12 months without a known cause, is a challenging clinical scenario. It can be indicative of a myriad of underlying conditions, ranging from malignancies to chronic infections, and therefore demands a comprehensive, systematic approach.
The first step in the assessment of UWL is a thorough history and physical examination. Special attention should be given to dietary intake, physical activity, psychological status, and medication use. The presence of symptoms like fever, pain, or changes in bowel habits might suggest specific etiologies.
Basic laboratory investigations, including complete blood count, renal and liver function tests, thyroid function tests, and markers of inflammation, are usually conducted in all patients. Imaging studies, such as chest X-ray or abdominal ultrasound, may be considered based on the patient's symptoms and risk factors. More targeted investigations, like endoscopy or biopsy, may be needed if initial tests are inconclusive.
Management strategies for UWL depend on the underlying cause. In some cases, symptom management and nutritional support may be all that's required. In others, specific treatments for identified diseases are necessary. It's crucial to involve a multidisciplinary team, including dietitians and psychologists, in the patient's care.
The approach to UWL in clinical practice requires careful evaluation, a high index of suspicion, and a patient-centered approach. By combining a thorough history, physical examination, and appropriate investigations, clinicians can effectively diagnose and manage the underlying causes of UWL. Continued research is needed to improve our understanding and management of this complex clinical scenario.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation